BioLargo Inc (OTCQB:BLGO) said its subsidiary Clyra Medical Technologies Inc has appointed two medical industry veterans, Nicholas Valeriani and Linda Park, as new members of its board of directors
Valeriani has decades of executive experience in the medical device industry, including 34 years at Johnson & Johnson where he led several corporate functions and was a member of its executive committee, while Park is a trusted executive and legal professional with a proven track record of supporting and advising public companies, the company said.
"We are so pleased that Nicholas and Linda have joined Clyra's board of directors," said Steve Harrison, president of Clyra Medical Technologies in a statement. "Nicholas and Linda both have extensive experience in the medical industry successfully executing on projects to take medical products to market - a monumental task we are currently engaged in."
READ: BioLargo's 2022 revenue doubles up 2021 in new preliminary results
“We believe their expertise will be invaluable as Clyra works to execute agreements in licensing, distributing, and marketing its innovative medical products, including its first - BioClynse, a patented, FDA 510(k)-cleared wound irrigation product that is gentle but effective while not generating antimicrobial resistance.," Harrison added.
Dennis P Calvert, president and CEO of BioLargo, commented: "We are so pleased that Clyra now has a clear path ahead of them to commercialize the incredible products they developed based off of BioLargo's patented technology. We know that with experts like Nicholas Valeriani and Linda Park providing key guidance, Clyra's future is extremely bright."
Key positions held by Valeriani at Johnson & Johnson included corporate vice president of human resources, worldwide chairman of medical devices and diagnostics, and vice president in the Office of Strategy and Growth. He currently serves on the board of directors for Edwards Lifesciences, Surgalign Inc, SPR Therapeutics, and AgNovos Bioscience.
In addition, Valeriani serves on the board of the Gary and Mary West Health Institute, an independent non-profit medical research organization whose mission is to enable seniors to successfully age in place with access to high-quality, affordable healthcare and support services. He holds a Bachelor's degree in Industrial Engineering and an MBA from Rutgers University.
Meanwhile, Park has corporate board and executive experience at billion-dollar corporations such as her current roles working with Edwards Lifesciences in her capacity as corporate secretary, senior vice president and associate general counsel, and board member of the Edwards Lifesciences Foundation, and prior work with Western Digital Corporation.
She brings over 20 years of experience advancing organizations' corporate governance and strategic goals and has many years of experience advising issuer and investment banking clients on corporate and securities matters, mergers and acquisitions, bank financings and capital markets, including initial public offerings.
She is also an active partner and thought leader on environmental, social, and corporate governance issues. Park has an undergraduate degree from Johns Hopkins University, and a law degree from Duke University School of Law.
BioLargo is a cleantech and life sciences innovator and engineering services solution provider. Its core products address PFAS contamination, achieve advanced water and wastewater treatment, control odor and VOCs, improve air quality, and control infections and infectious disease.
The company’s approach is to invent or acquire novel technologies, develop them into product offerings, and extend its commercial reach through licensing and channel partnerships to maximize their impact.
Contact the author at jon.hopkins@proactiveinvestors.com